176 related articles for article (PubMed ID: 2587675)
1. [Psychometric findings in treatment using the selective MAO-A inhibitors moclobemide and maprotiline].
Classen W
Psychiatr Prax; 1989 Aug; 16 Suppl 1():41-3. PubMed ID: 2587675
[TBL] [Abstract][Full Text] [Related]
2. Psychometric alterations in treatment with the MAO-A-inhibitor moclobemide.
Classen W; Laux G
J Neural Transm Suppl; 1990; 32():185-8. PubMed ID: 2089088
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
Becker T; Struck M; Laux G
Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856
[TBL] [Abstract][Full Text] [Related]
4. Moclobemide and maprotiline in the treatment of inpatients with major depressive disorder.
Laux G; Beckmann H; Classen W; Becker T
J Neural Transm Suppl; 1989; 28():45-52. PubMed ID: 2677241
[TBL] [Abstract][Full Text] [Related]
5. Multicenter double-blind study of moclobemide and maprotiline.
Vaz-Serra A; Figueira ML; Firmino H; Albuquerque AJ; Jara JM; Pestana LC
Clin Neuropharmacol; 1994; 17 Suppl 1():S38-49. PubMed ID: 7954483
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
König F; Wolfersdorf M
Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
[TBL] [Abstract][Full Text] [Related]
7. [The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
Binz U; Wendt G
Fortschr Med; 1982 Dec; 100(45):2111-7. PubMed ID: 6757074
[No Abstract] [Full Text] [Related]
8. [Moclobemide in the long-term treatment of depressed patients].
Carl G; Laux G
Psychiatr Prax; 1989 Aug; 16 Suppl 1():48-50. PubMed ID: 2511580
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners.
Gachoud JP; Dick P; Köhler M
Clin Neuropharmacol; 1994; 17 Suppl 1():S29-37. PubMed ID: 7954482
[TBL] [Abstract][Full Text] [Related]
10. [Double-blind comparison of the effects of a new tricyclic antidepressant (Lofepramine) and a tetracyclic antidepressant (maprotiline)].
Obermair W; Pöldinger W
Int Pharmacopsychiatry; 1977; 12(2):65-71. PubMed ID: 330440
[TBL] [Abstract][Full Text] [Related]
11. Maprotiline versus imipramine and placebo in neurotic depression.
van der Velde CD
J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
[TBL] [Abstract][Full Text] [Related]
12. Trimipramine and maprotiline plasma levels during combined treatment with moclobemide in therapy-resistant depression.
König F; Wolfersdorf M; Löble M; Wössner S; Hauger B
Pharmacopsychiatry; 1997 Jul; 30(4):125-7. PubMed ID: 9271778
[TBL] [Abstract][Full Text] [Related]
13. Treatment of atypical depression with moclobemide: a sequential double controlled study.
Schweitzer I; Tiller J; Maguire K; Davies B
Int J Clin Pharmacol Res; 1989; 9(2):111-7. PubMed ID: 2654034
[TBL] [Abstract][Full Text] [Related]
14. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
Schmauss M; Laakmann G; Dieterle D; Blaschke D
Pharmacopsychiatry; 1985 Jul; 18(4):282-5. PubMed ID: 3895255
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological parameters as predictors for antidepressant drug responses in depressed patients.
Fähndrich E
Pharmacopsychiatria; 1983 Nov; 16(6):179-85. PubMed ID: 6665027
[TBL] [Abstract][Full Text] [Related]
17. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
[TBL] [Abstract][Full Text] [Related]
18. Moclobemide compared with second-generation antidepressants in elderly people.
De Vanna M; Kummer J; Agnoli A; Gentili P; Lorizio A; Anand R
Acta Psychiatr Scand Suppl; 1990; 360():64-6. PubMed ID: 2248077
[TBL] [Abstract][Full Text] [Related]
19. [The effect of maprotiline on target symptoms of depressive states].
Faltus F
Act Nerv Super (Praha); 1982 May; 24(2):99-100. PubMed ID: 7102230
[No Abstract] [Full Text] [Related]
20. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
Kok LP; Tsoi WF
Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
